homocysteine and Cytomegalic Inclusion Disease

homocysteine has been researched along with Cytomegalic Inclusion Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Branzi, A; Carigi, S; Coccolo, F; Grigioni, F; Kessels, K; Koessels, K; Magelli, C; Magnani, G; Marrozzini, C; Marzocchi, A; Musuraca, AC; Ortolani, P; Potena, L; Russo, A; Sassi, S1
Baltar, JM; de Oña, M; Díez, B; Gómez, E; Laurés, A; Melón, S1

Trials

1 trial(s) available for homocysteine and Cytomegalic Inclusion Disease

ArticleYear
Homocysteine-lowering therapy and early progression of transplant vasculopathy: a prospective, randomized, IVUS-based study.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:9

    Topics: Adult; Cytomegalovirus Infections; Disease Progression; Female; Folic Acid; Heart Diseases; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Hyperplasia; Male; Middle Aged; Prospective Studies; Research Design; Risk Factors; Tetrahydrofolates; Time Factors; Ultrasonography; Vascular Diseases

2005

Other Studies

1 other study(ies) available for homocysteine and Cytomegalic Inclusion Disease

ArticleYear
Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.
    Transplantation proceedings, 2005, Volume: 37, Issue:9

    Topics: Adolescent; Adult; Aged; Cytomegalovirus; Cytomegalovirus Infections; Female; Herpes Simplex; Herpesviridae; Homocysteine; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Risk Factors; Time Factors; Virus Replication

2005